Corteva (NYSE:CTVA) PT Set at $87.00 by Oppenheimer

Corteva (NYSE:CTVA - Get Free Report) received a $87.00 price target from stock analysts at Oppenheimer in a note issued to investors on Tuesday, MarketBeat Ratings reports. The firm currently has an "outperform" rating on the stock. Oppenheimer's price objective points to a potential upside of 19.43% from the company's previous close.

CTVA has been the topic of a number of other reports. UBS Group boosted their price target on shares of Corteva from $76.00 to $90.00 and gave the stock a "buy" rating in a research report on Wednesday, July 9th. Royal Bank Of Canada upped their price objective on shares of Corteva from $74.00 to $85.00 and gave the stock an "outperform" rating in a report on Thursday, July 10th. Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price objective on the stock in a report on Monday, March 31st. Citigroup increased their target price on shares of Corteva from $75.00 to $78.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Finally, Morgan Stanley increased their target price on shares of Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Corteva presently has a consensus rating of "Moderate Buy" and an average price target of $77.38.

Corteva Stock Performance

CTVA traded down $0.32 on Tuesday, reaching $72.85. The stock had a trading volume of 1,481,566 shares, compared to its average volume of 3,441,410. The company has a market cap of $49.69 billion, a P/E ratio of 44.38, a price-to-earnings-growth ratio of 1.85 and a beta of 0.76. The business's 50-day moving average price is $72.19 and its two-hundred day moving average price is $65.03. The company has a current ratio of 1.44, a quick ratio of 1.00 and a debt-to-equity ratio of 0.07. Corteva has a 12-month low of $50.30 and a 12-month high of $77.41.

Corteva (NYSE:CTVA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $0.88 by $0.25. The business had revenue of $4.42 billion during the quarter, compared to analysts' expectations of $4.56 billion. Corteva had a net margin of 6.77% and a return on equity of 7.84%. The company's quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.89 earnings per share. Sell-side analysts forecast that Corteva will post 2.96 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Scissortail Wealth Management LLC grew its position in Corteva by 72,080.0% during the 4th quarter. Scissortail Wealth Management LLC now owns 3,609 shares of the company's stock worth $206,000 after purchasing an additional 3,604 shares during the last quarter. Allworth Financial LP lifted its stake in shares of Corteva by 11.8% in the 1st quarter. Allworth Financial LP now owns 15,313 shares of the company's stock worth $945,000 after acquiring an additional 1,614 shares during the period. DnB Asset Management AS lifted its stake in shares of Corteva by 39.0% in the 4th quarter. DnB Asset Management AS now owns 232,902 shares of the company's stock worth $13,266,000 after acquiring an additional 65,334 shares during the period. Brighton Jones LLC lifted its stake in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company's stock worth $888,000 after acquiring an additional 11,760 shares during the period. Finally, Farther Finance Advisors LLC lifted its stake in shares of Corteva by 13.9% in the 1st quarter. Farther Finance Advisors LLC now owns 4,387 shares of the company's stock worth $279,000 after acquiring an additional 536 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.